Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EV/Core EBITDA

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.4926.404.985.735.29

What is the latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM ?

The latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM is 9.49 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20259.49
Mar202426.40
Mar20234.98
Mar20225.73
Mar20215.29

How is EV/Core EBITDA of SAMRAT PHARMACHEM Trending?

Years EV/Core EBITDA % Change
Mar2025 9.49
-64.05
Mar2024 26.4
430.12
Mar2023 4.98
-13.09
Mar2022 5.73
8.32
Mar2021 5.29 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EV/Core EBITDA ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹76.4 Cr -4.6% -8.6% -39.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,581.0 Cr -1.6% 4.6% -0.8% Stock Analytics
DIVIS LABORATORIES ₹167,051.0 Cr -2.5% -6% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,367.0 Cr 1.2% -1.4% 11.8% Stock Analytics
CIPLA ₹120,289.0 Cr -1.2% -1.5% -0.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,421.0 Cr -2.7% 4% 2.2% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-4.6%

-8.6%

-39.7%

SENSEX

-0.8%

1%

3.2%


You may also like the below Video Courses